ACE Conference and Expo (Feb. 23-26, 2022) — American College of Apothecaries (ACA)

Join Us in Puerto Rico — In Person! The Annual Conference & Expo 2022 for independent pharmacists will be held in person in Puerto Rico Feb. 23-26, 2022, at the Wyndham Grand Rio Mar Beach & Gulf Resort encircling a tropical beach/rainforest setting. Presented by American College of Apothecaries, American College of Veterinary Pharmacists and […]

CE: Raw Materials Revealed

Wed, Sep 29, 2021 2:00 PM – 3:00 PM EDT Using quality raw materials in compounding is important to mitigate patient safety risks. This session will reveal components of raw materials and the tests conducted to confirm the quality of a pure ingredient. Attendees will examine certificates of analysis, evaluate raw material test failures, and […]

Biomarkers for Diagnosis and Prognosis of MS

It is an exciting period for the clinical management of multiple sclerosis (MS), with an expanding treatment landscape and recent approval of new disease-modifying therapies (DMTs) for both relapsing and progressive MS. The Consortium of Multiple Sclerosis Centers (CMSC) 2019 Annual Meeting, the largest MS meeting in North America, features the latest information on cutting-edge […]

Navigating the New Psoriasis Guidelines: Implications for Clinical Practice

The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have recently released new joint guidelines that outline best practices for the management of psoriasis (PsO) with biologics, the need for awareness and attention to comorbidities, and guidelines for pediatric PsO treatment. Clinicians must ensure that they are aware of these guidelines and […]

A Deeper Dive into NASH Diagnosis and Treatment: An Augmented Reality Experience

Obesity and diabetes are on the rise, leading to an increased prevalence of non-alcoholic fatty liver disease (NAFLD), which in some cases may progress to non-alcoholic steatohepatitis (NASH). NAFLD effects approximately 30% of the U.S. population, with NASH effecting about 5%. NASH comes with a significant risk of progression to advanced liver fibrosis, cirrhosis, and […]

Managing Adverse Effects with Multimodal Cancer Therapy: Pharmacists Perspectives

Managing Adverse Effects with Multimodal Cancer Therapy: Pharmacists Perspectives Upon completion of this program, participants should be better able to: -Discuss the rationale for combination therapy in cancer care    -Compare and contrast adverse effects related to the use of targeted therapies, immunotherapy, and cytotoxic chemotherapy -Describe the impact on adverse effects when targeted therapies […]

SUBSCRIBE

Please enable JavaScript in your browser to complete this form.
Name
Subscription Choices
Checkboxes

Request information from Generational Shift: Why We Should Modify our Instructional Strategies for the Next Generation of Pharmacists

Please enable JavaScript in your browser to complete this form.
Name
Address
Subscribe